Valeo Pharma Inc (VPH.TO)
0.105
-0.01
(-8.70%)
CAD |
TSX |
May 03, 16:00
Valeo Pharma Total Liabilities (Quarterly): 87.37M for Jan. 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 87.37M |
| October 31, 2023 | 81.54M |
| July 31, 2023 | 80.58M |
| April 30, 2023 | 77.53M |
| January 31, 2023 | 71.36M |
| October 31, 2022 | 76.11M |
| July 31, 2022 | 73.82M |
| April 30, 2022 | 27.58M |
| January 31, 2022 | 29.23M |
| October 31, 2021 | 18.98M |
| July 31, 2021 | 16.40M |
| Date | Value |
|---|---|
| April 30, 2021 | 17.31M |
| January 31, 2021 | 6.904M |
| October 31, 2020 | 7.894M |
| July 31, 2020 | 9.218M |
| April 30, 2020 | 8.682M |
| January 31, 2020 | 7.491M |
| October 31, 2019 | 5.829M |
| July 31, 2019 | 4.802M |
| April 30, 2019 | 5.334M |
| January 31, 2019 | 6.014M |
| October 31, 2018 | 4.752M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.802M
Minimum
Jul 2019
87.37M
Maximum
Jan 2024
37.30M
Average
18.98M
Median
Oct 2021
Total Liabilities (Quarterly) Benchmarks
| Biocure Technology Inc | 0.9098M |
| Core One Labs Inc | 1.759M |
| Nova Mentis Life Science Corp | 0.6549M |
| Nanosphere Health Sciences Inc | 2.040M |
| Lobe Sciences Ltd | 2.871M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.35M |
| Shareholders Equity (Quarterly) | -47.01M |
| Debt to Equity Ratio | -1.369 |
| Current Ratio | 0.4855 |
| Net Debt Paydown Yield | -2.76% |